FORT LAUDERDALE, Fla. — The rates of noninfectious vitritis and infectious endophthalmitis after anti-VEGF injections were low but varied between anti-VEGF agents, a speaker said here.
“The results suggest a difference in rates of noninfectious vitritis depending on the anti-VEGF agent used. Aflibercept had more frequency,” Andre P. Muralha, MD, said at the Retina World Congress.
Muralha presented the results of a retrospective monocentric study evaluating the incidences of noninfectious vitritis and infectious endophthalmitis after intravitreal injections of anti-VEGF agents.
Uncategorized